| AD | Alzheimer’s disease |
| AMPK | AMP-activated protein kinase |
| AMD | Age-related macular degeneration |
| ATGL | Adipose triglyceride lipase |
| CRP | C-reactive protein |
| FFM | Fat-free mass |
| FoxO3a | Forkhead box O3a |
| GSK3β | Glycogen synthase kinase-3 beta |
| HSL | Hormone-sensitive lipase |
| MASTERS | Metformin to augment strength training effective response in seniors |
| MET | Metformin |
| mTORC1 | Mammalian target of rapamycin complex 1 |
| MPCs | Muscle progenitor cells |
| MuRF1 | Muscle RING finger protein-1 |
| NA | Not applicable |
| NS | Not significant |
| PD | Parkinson’s disease |
| Pos | Positive effect |
| Neg | Negative effect |
| SASP | Senescence-associated secretory phenotype |
| SCFA | Short-chain fatty acid |
| T2DM | Type 2 diabetes mellitus |
| TAME | Targeting aging with metformin |